Onychomycosis
📧 Sign up to get email alerts when something new happens for Onychomycosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-12-26FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sandoz Inc)
FDA approved a generic version of griseofulvin (Ultramicrosize Griseofulvin) from Sandoz Inc under an Original Application (ANDA 202805) for…
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study [Phase 2]
Phase 2b randomized, double-blind trial for onychomycosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy in onychomycosis of the great toenail.
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer [Phase 4]
Phase 4 trial comparing amorolfine 5% nail lacquer to ciclopirox nail lacquer for treatment of onychomycosis; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis [Phase 3]
Phase 3 trial evaluating P-3058 10% nail solution for toenail onychomycosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Anti-mold Azole in the Prophylaxis for Invasive Fusariosis [NA]
Clinical trial update for an anti-mold azole used as prophylaxis for invasive Fusariosis; trial completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail [Phase 2]
Phase 2 trial update on NVXT Solution for mild-to-moderate fungal toenail infection (onychomycosis) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: A Study of the Systemic Absorption of MOB015B [Phase 1]
Phase 1 study assessing the systemic absorption of MOB015B in onychomycosis has been completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents [Phase 4]
Phase 4 clinical trial update evaluating the safety and pharmacokinetics of tavaborole topical solution for fungal toenail infections (onych…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Laser Therapy for Onychomycosis in Patients Wih Diabetes at Risk for Diabetic Foot Complications [NA]
A completed clinical trial evaluating laser therapy for onychomycosis in diabetic patients at risk for foot complications.
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population [Phase 3]
Phase 3 clinical trial update for P-3058 Nail Solution in children with onychomycosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis [Phase 2]
Phase 2 trial evaluating safety and efficacy of topically applied AN2690 solutions for onychomycosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-20Clinical Trial Update: Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) [Phase 2]
Phase 2 clinical trial updating absorption and systemic exposure of AN2690 in patients with onychomycosis (ADME II) completed.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis [Phase 2]
Phase 2 trial evaluating four dose regimens of oral albaconazole in distal subungual onychomycosis; efficacy and safety results have been po…
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail. [Phase 2]
Phase 2 trial evaluating PD P 506 A for distal subungual onychomycosis of the great toenail has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-22Clinical Trial Update: A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule [Phase 1]
Phase 1 study comparing the blood levels of albaconazole when given as a tablet versus a capsule in healthy subjects to evaluate pharmacokin…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus [Phase 1]
This Phase 1 study completed evaluating escalating doses of a drug for the treatment of onychomycosis (nail fungus) sponsored by Stiefel, a …
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Antifungal Drugs in Treatment of Onychomycosis [Phase 3]
A Phase 3 clinical trial update evaluating antifungal drugs for onychomycosis; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis [Phase 2]
This document reports a Phase 2 clinical trial evaluating CELEXT07 for treating onychomycosis (toe nail fungal infection). The current statu…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis [NA]
A completed clinical trial evaluating how well a fungal nail treatment improves the visual signs of toenail onychomycosis.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis [Phase 3]
A Phase 3 clinical trial is assessing the efficacy and safety of an investigational adjuvant treatment for onychomycosis.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment [NA]
This clinical trial compares methylene blue–mediated photodynamic therapy with 5% amorolfine nail lacquer for toenail onychomycosis, assessi…
-
CLINICAL_TRIALS research · 2017-02-20Clinical Trial Update: Laser Treatment for Onychomycosis in Diabetes [NA]
Clinical trial update on laser treatment for onychomycosis in people with Type 2 diabetes mellitus.
-
FDA approval · 2016-09-26FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for itraconazole, granting a generic version of the antifungal medication. Th…
-
FDA approval · 2016-09-22FDA Approved: JUBLIA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for JUBLIA (efinaconazole) submitted by Bausch Health US LLC to update the product labeling.